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LMP2A deletion and point mutants, with mutations in phosphotyrosine-containing protein–protein interaction motifs, were
transiently expressed in 293 cells and their phosphorylation was examined in immune complex kinase assays as well as in
vivo. In vitro LMP2A phosphorylation depended on tyrosine 112. In vivo, mutations of single tyrosines did not eliminate LMP2
phosphorylation, although mutation of the LMP2A ITAM decreased LMP2A phosphorylation. The relationship between
LMP2A in vitro phosphorylation and that induced by cell-extracellular matrix (ECM) interactions was also investigated. While
LMP2A was phosphorylated to higher levels in whole-cell extracts of stimulated cells, a difference in in vitro kinase assays
with extracts from stimulated and unstimulated cells was not detected, indicating that the ECM-mediated regulation of
LMP2A phosphorylation is lost in vitro. In the presence of LMP2A, several cellular proteins with molecular weights between
70 and 80 kDa were phosphorylated on tyrosine. This increase in cellular protein phosphorylation depended on the LMP2A
ITAM motif and suggests that the ITAM may participate in signal-transduction events in epithelial cells. © 2001 Elsevier ScienceINTRODUCTION
Epstein–Barr virus (EBV), a ubiquitous human herpes-
virus, establishes latent infection in B cells with periodic
reactivation of virus and reinfection of oropharyngeal
epithelia. EBV is the causative agent of infectious mono-
nucleosis and is associated with several human can-
cers, such as the lymphoid diseases Burkitt’s lymphoma,
posttransplant lymphoma, and Hodgkin’s disease, as
well as nasopharyngeal carcinoma (NPC), an epithelial
malignancy (Kieff, 1996). LMP2A inhibits B cell receptor
signaling through dominant negative effects on protein
tyrosine kinases (Miller et al., 1995, 1994a,b, 1993). In
latently infected cells, LMP2A apparently acts as a decoy
receptor and sequesters signaling molecules, preventing
their activation in response to B cell receptor crosslink-
ing (Burkhardt et al., 1992; Longnecker et al., 1991). Inhi-
bition of these signaling events results in a block in the
activation of transcription factors which would stimulate
expression of EBV immediate-early genes and induce
viral lytic cycle replication. In vivo, LMP2A provides both
a development and a survival signal in B cells in the
absence of normal B cell receptor signals in LMP2A-
expressing transgenic mice (Caldwell et al., 1998). Re-
cent studies suggest that this signal may be a result of
the specific activation of Akt by LMP2A, which has been
observed both in epithelial and in B cells (Scholle et al.,
2000; Swart and Longnecker, 2000). In particular, the
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208expression of LMP2A has dramatic effects on the growth
of epithelial cells (Scholle et al., 2000).
Tyrosine-containing protein–protein interaction motifs
in the LMP2A amino terminus play critical roles in me-
diating these effects. Tyrosine Y112, found in the context
of a YEEA sequence, closely resembles the consensus
binding site for the SH2 domain of Src family kinases,
YEEI (Songyang et al., 1993). Binding of Lyn and Fyn to
this motif leads to subsequent phosphorylation of the
LMP2A immunoreceptor tyrosine-based activation motif
(ITAM) at tyrosines 74 and 85. The phosphorylated ITAM
motif serves as a docking site for the tandem SH2 do-
mains of Syk, a hematopoietic cell-specific kinase (Reth,
1989; Weiss and Littman, 1994). Mutation of either of
these motifs renders LMP2A nonfunctional in inhibition
of B cell receptor-signal transduction (Fruehling and
Longnecker, 1997; Fruehling et al., 1998). Several other
tyrosine-containing motifs in the LMP2A amino terminus
have been suggested to constitute binding sites for SH2
domains of important cellular signaling molecules such
as the docking protein Shc and the 85-kDa regulatory
subunit of PI3-kinase (Miller et al., 1995). The amino acid
sequence surrounding tyrosine 101 has been suggested
to potentially mediate binding to the SH2 domain of Csk,
a negative regulator of Src. LMP2A is consistently ex-
pressed in NPC and in nude mouse passaged NPC
tumors, suggesting that it is an important factor in epi-
thelial cell infection (Brooks et al., 1992; Busson et al.,
1992). LMP2A interacts with protein kinases in epithelial
cells and its phosphorylation is induced by cell–ECM
interactions (Scholle et al., 1999).
To further investigate potential effects on epithelial
209EPSTEIN BARR VIRUS LMP2A IN EPITHELIAL CELLSsignaling pathways that are affected by LMP2A, the in-
dividual tyrosine-containing motifs in the LMP2A N-ter-
minus were examined for their importance for LMP2A
phosphorylation in epithelial cells in vitro and in vivo
using LMP2A point and deletion mutants. The results
reveal differences in the protein–protein interaction mo-
tifs required for in vitro and in vivo phosphorylation. Both
the LMP2A ITAM motif and the tyrosine Y112, important
for LMP2A function in B lymphocytes, were also involved
in LMP2A phosphorylation in epithelial cells. In addition,
determination of the phosphorylation status of cellular
proteins in the presence and absence of LMP2A re-
vealed that tyrosine phosphorylation of at least three
FIG. 1. LMP2A deletion and point mutants. Protein–protein interac-
tion motifs are progressively deleted in the deletion mutants. D80–112
also has a point mutation at tyrosine Y74 (*). The ITAM motif is deleted
in both D21–85 and D80–112. All LMP2A point mutants contain single
tyrosine-to-phenylalanine substitutions with the exception of LMP2A
Y74/85F, which has both tyrosines in the ITAM motif mutated.cellular proteins was increased in the presence of
LMP2A and was dependent on the LMP2A ITAM motif.
D21–85 and D80–112 are not phosphorylated. The bottom panel detects LMP2A
point mutants. All point mutants, except Y112F, are phosphorylated comparedRESULTS
LMP2A deletion and point mutants
The LMP2A amino terminus contains numerous pro-
tein–protein interaction motifs, most of which contain
tyrosines, and are potential docking sites for cellular
proteins when phosphorylated. A diagram of the various
LMP2A deletion mutants and potential tyrosine phos-
phorylation sites is shown in Fig. 1. Tyrosine Y112 is in
the context of a sequence YEEA, resembling the Src
family kinase SH2 domain interaction motif. Tyrosine 74
and 85 constitute the LMP2A ITAM motif. ITAMs are
characterized by the consensus sequence (YXXL/I)(X6–8)
(YXXL/I). Protein–protein interaction motifs are progres-
sively deleted in the deletion mutants. In addition to
deletion of tyrosines 85, 101, and 112, D80–112 also has
a point mutation in tyrosine 74, eliminating the ITAM.
D21–85 deletes most of the tyrosines in the N-terminus,
including the ITAM, but retains Y101 and Y112. Addition-
ally, a set of point mutants was used in this study, which
are single substitution mutants of individual tyrosines
with the exception of Y74/85F, which contains a double
mutation in the ITAM motif.
LMP2A phosphorylation status in in vitro kinase
assays
The LMP2A deletion and point mutants were tran-
siently transfected into 293 cells and in vitro kinase
assays were performed on immune complexes contain-
ing LMP2A. Wild-type LMP2A was highly phosphory-
lated, as were the deletion mutants D21–36 and D21–64.
In contrast, the deletion mutants D21–85 and D80–112
were not phosphorylated in in vitro kinase assays (Fig.
2A). The ITAM motif is deleted or mutated in the latter two
mutants and D80–112, in addition, is deleted for tyrosine
Y112, the Src family kinase interaction site, suggesting
an important role for these motifs in LMP2A in vitro
phosphorylation.
In the context of the LMP2A point mutants, mutation ofFIG. 2. LMP2A phosphorylation in in vitro kinase assays. LMP2A and mutants were immunoprecipitated from transiently transfected 293 cell lysates
followed by immune-complex kinase assays. (A) LMP2A wt and the deletion mutants D21–36 and D21–64 are highly phosphorylated. Deletion mutantsand mutant protein expression. (B) In vitro phosphorylation of LMP2A
to wild-type LMP2A. The bottom panel shows LMP2A protein levels.
210 SCHOLLE, LONGNECKER, AND RAAB-TRAUBtyrosine Y112 inhibited in vitro phosphorylation, while all
other LMP2A point mutants were phosphorylated to wild-
type levels (Fig. 2B). These results indicate that Y112 is
the primary site of phosphorylation in vitro. However, the
deletion mutant, D21–85, retained Y112 and was not
phosphorylated. This may indicate that phosphorylation
of Y112 requires a conformation that is lost in the large
deletion mutant.
Constitutive LMP2A phosphorylation
It was of interest to investigate the phosphorylation
state of the various LMP2A mutants in intact cells to
determine whether in vitro and in vivo phosphorylation
behaviors are consistent. Therefore LMP2A deletion and
point mutants were transiently transfected into 293 cells
and constitutive LMP2A tyrosine phosphorylation was
examined by immunoblot and immunofluorescence. The
LMP2A deletion mutants showed the same phosphory-
lation pattern as in the immune complex kinase assays
with phosphorylation of D21–36 and D21–64 and ab-
sence of phosphorylation of D21–85 and D80–112 (Fig. 3).
Although mutations in the LMP2A ITAM motif, as illus-
trated with the mutants Y74F, Y74/85F, and Y85F, consis-
tently reduced the levels of LMP2A tyrosine phosphory-
lation, all forms of LMP2 were phosphorylated at variable
levels in vivo.
Immunofluorescence analysis of LMP2A and selected
mutants detected LMP2A predominantly in the perinu-
clear cytoplasm of transfected cells (Fig. 4). Using phos-
photyrosine (pTyr)-specific antibodies, phosphotyrosine
was readily detected in areas where LMP2A was
present. The computer-generated overlay image re-
vealed colocalization of the phosphotyrosine reactivity
with LMP2A, as indicated by yellow staining. The immu-
nofluorescence staining confirmed that the deletion mu-
tants D21–85 and D80–112 were not phosphorylated or
phosphorylated to significantly lower levels than WT
LMP2A in vivo as little pTyr was detected even with very
FIG. 3. Phosphorylation of LMP2A deletion and point mutants in vivo.
Western blot analysis of 293 cell lysates, transiently transfected with
wild-type or mutant LMP2A expression constructs. WT and deletion
mutants D21–36 and D21–64 are phosphorylated while D21–85 and
D80–112 are not. Mutation of the ITAM motif in the mutants Y74f,
Y64/85F, and Y85F reduces the phosphotyrosine content. Bottom: Ex-
pression levels of LMP2A and mutants.long exposure of pTyr staining of these mutants and as
indicated by the orange color of the overlay. Although asdetected by immunoblots, the Y74/85F mutant had re-
duced phosphotyrosine compared to the Y112F mutant
(Fig. 3), phosphotyrosine was readily detected by immu-
nostaining for both mutants and this phosphotyrosine
colocalized with both mutated forms of LMP2A. The co-
localization of phosphotyrosine with LMP2A Y74/85F
when LMP2A itself had reduced phosphorylation may
indicate colocalization of LMP2A and a phosphoprotein,
possibly an LMP2A-interacting kinase.
Differences in ECM-induced and in vitro LMP2A
phosphorylation
Cell–ECM interactions induce tyrosine phosphoryla-
tion of LMP2A (Scholle et al., 1999). To determine
whether the protein kinase(s) associated with LMP2A
after immunoprecipitation is activated upon cell–ECM
adhesion, LMP2A was immunoprecipitated from extracts
of transiently transfected cells kept in suspension for 45
min or plated on fibronectin for 45 min and in vitro kinase
assays were performed on the immune complexes. An
increase in radioactive phosphate incorporation into
LMP2A in fibronectin-stimulated cells over cells kept in
suspension was not detected (Fig. 5). However, determi-
nation of the total phosphotyrosine content of LMP2A by
immunoblot of whole-cell extracts prior to immunopre-
cipitation revealed that LMP2A was phosphorylated to
higher levels in fibronectin-stimulated cells in whole-cell
extracts. These data indicate that the regulation of ECM-
induced LMP2A phosphorylation does not occur in im-
munoprecipitation/in vitro kinase assays. These results
suggest that the adhesion-enhanced kinase activity is
distinct from the activity detected in vitro. The adhesion-
enhanced kinase activity might be regulated through
protein–protein interactions with the cytoskeleton or
within a specific cellular localization, features that would
be lost upon disruption of the cells and immunoprecipi-
tation.
LMP2A expression induces the phosphorylation of
cellular proteins
LMP2A expression affects the phosphorylation state
of several cellular proteins in B cells. Syk and the regu-
latory 85-kDa subunit of PI3-kinase, for example, are
constitutively phosphorylated to higher levels in LMP2A-
expressing B lymphocytes (Miller et al., 1995). The phos-
phorylation state of these molecules does not change in
response to B cell receptor stimulation, in contrast to
non-LMP2A-expressing cells. To identify effects of
LMP2A expression on cellular signaling pathways in
epithelial cells, the phosphorylation state of cellular pro-
teins in the presence or absence of LMP2A was exam-
ined in more detail. Transient transfection of LMP2A into
293 cells allowed a high level of LMP2A expression and
resulted in induction of phosphorylation at variable levels
of at least three cellular proteins with estimated molec-
tion in
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induction of cellular protein phosphorylation was appar-
ent in cells kept in suspension and could be further
enhanced by fibronectin stimulation (Fig. 6B).
Although immunoblotting for HA revealed an equiva-
lent expression of all of the LMP2A mutants, the LMP2A-
deletion mutants that were not phosphorylated in epithe-
lial cells, D21–85 and D80–112, did not induce phosphor-
ylation of these proteins (Fig. 6C). In the context of the
LMP2A point mutants, the induction of tyrosine phos-
phorylation of pp80 was dependent on the ITAM motif,
since all three mutants in which either a single tyrosine
or both tyrosines in the ITAM were mutated, Y74F, Y74/
85F, and Y85F, did not cause upregulation of pp80 phos-
FIG. 4. Immunofluorescence analysis of the phosphorylation state o
mutant expression constructs, seeded onto coverslips, and phosphotyro
demonstrates colocalization of the major phosphotyrosine reactivity an
ylation. Mutation of Y112 does not interfere with LMP2A phosphoryla
phosphorylated in intact cells (D21–85 and D80–112).phorylation.
Analysis of the total phosphotyrosine pattern with thedeletion mutants after adhesion to fibronectin confirmed
that phosphorylation of pp80 was increased by adhesion
(Fig. 6D). The adhesion-induced phosphorylation was
variable; however, the mutants D21–85 and D80–112 did
not induce phosphorylation of these proteins. These data
suggest that the ITAM motif contributes to potential ef-
fects of LMP2A on epithelial cell signaling pathways,
although the nature of those pathways still remains to be
identified.
DISCUSSION
The phosphorylation status of LMP2A in epithelial
cells in vitro and in vivo was investigated using a com-
A and mutants. 293 cells were transiently transfected with LMP2A or
aining (left) and HA staining (middle) was performed. The overlay (right)
2A. Double mutation of the ITAM does not abolish LMP2A phosphor-
vivo. Deletion mutants that are not phosphorylated in vitro are notf LMP2
sine st
d LMPbination of deletion and point mutants. Several phospho-
tyrosine-containing protein–protein interaction motifs
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LMP2A function in B lymphocytes were found to be
involved in LMP2A phosphorylation in epithelial cells as
well. In vitro, LMP2A phosphorylation was dependent on
the presence of tyrosine 112, found in the context of a
YEEA sequence, the interaction site for Src family ki-
nases in B cells (Fruehling et al., 1998). These data
suggest that Y112 is important for the interaction of a
protein kinase in vitro with the LMP2A amino terminus as
both mutants that have Y112 deleted, D80–112 and Y112F,
are not phosphorylated. The absence of phosphorylation
of D21–85, which retains Y112, suggests that LMP2 con-
formation contributes to phosphorylation at this site. The
strong phosphorylation in vitro of Y74/85F also suggests
that the ITAM is not the site of phosphorylation in vitro.
While mutation of Y112 eliminated LMP2A phosphoryla-
tion in vitro, the Y112 point mutant was phosphorylated to
varying levels in intact cells. The requirement for this
docking site therefore is less stringent in vivo than in
vitro. It is possible that a direct, strong interaction with
this tyrosine is required in immunoprecipitation assays
to coprecipitate a protein kinase with LMP2A, whereas in
intact cells colocalization of LMP2A and other kinases
due to cytoskeletal interactions or a specific subcellular
localization results in LMP2A phosphorylation.
Although mutation of Y112 did not significantly affect
LMP2 phosphorylation in vivo, mutation of the ITAM con-
sistently reduced tyrosine phosphorylation of LMP2A,
indicating that the ITAM is phosphorylated in intact cells.
However, it is interesting to note that none of the point
mutations, including the double-ITAM mutation, com-
FIG. 5. LMP2A phosphorylation in vitro differs from cell adhesion
stimulated LMP2A phosphorylation. LMP2A was immunoprecipitated
from transiently transfected 293 cells, kept in suspension (0), or plated
on fibronectin for 45 min (45) and in vitro kinase assays were performed
on precipitated complexes. LMP2A did not incorporate more label in in
vitro kinase assays with stimulated cells than unstimulated cells (top).
Equal amounts of LMP2A were immunoprecipitated (middle). LMP2A in
whole-cell extracts (WCE) is phosphorylated to higher levels in stimu-
lated cells (bottom).pletely eliminated LMP2A phosphorylation. This is in
contrast to B lymphocytes where mutation of single pro-tein–protein interaction motifs is sufficient to abrogate
LMP2A phosphorylation (Fruehling et al., 1998).
Immunofluorescence analysis detected the majority of
LMP2A localized to the perinuclear cytoplasm, possibly
associated with the endoplasmic reticulum with very
little plasma membrane staining in transfected epithelial
cells. This is similar to previous reports in which LMP2A
was expressed in NIH 3T3 fibroblasts and detected in
the same location (Longnecker and Kieff, 1990). It is
possible that overexpression of LMP2A by transient
transfection leads to accumulation of the protein in the
ER; however, it is interesting to note that LMP2 is highly
phosphorylated, suggesting that it interacts with kinases
in this location.
In a previous study we demonstrated that LMP2A
FIG. 6. LMP2A induces the phosphorylation of cellular proteins.
Tyrosine-phosphorylated proteins were immunoprecipitated with an-
tiphosphotyrosine antibodies followed by phosphotyrosine immunoblot
(A). Three cellular proteins are increasingly phosphorylated in the
presence of LMP2A. (B) Cell-adhesion phosphorylation of the LMP2A-
induced proteins. Cells were either kept in suspension or plated on
fibronectin for 45 min followed by phosphotyrosine blot. (C) Induction of
cellular protein phosphorylation is ITAM-dependent. Deletion mutants
D21–85 and D80–112, as well as the point mutants Y74F, Y74/85F, and
Y85F, do not induce pp80 phosphorylation. (D) Adhesion-mediated
phosphorylation of cellular proteins is ITAM-dependent.
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ECM interactions (Scholle et al., 1999). In this study,
LMP2A, immunoprecipitated from lysates of cells stimu-
lated with fibronectin, was not phosphorylated to higher
levels in in vitro kinase assays than LMP2A immunopre-
cipitated from unstimulated cell extracts even though the
overall phosphotyrosine content of LMP2A after fibronec-
tin stimulation was greatly increased. These results sug-
gest that the in vitro kinase activity is distinct from the
kinase activity stimulated by adhesion. This may reflect a
requirement for specific cofactors or subcellular local-
ization for the adhesion activated kinase(s) to be active
that are lost during lysis and immunoprecipitation. As
previously reported, Csk, a negative regulator of Src
kinases, phosphorylated a GST–LMP2 fusion protein in
vitro and Csk also phosphorylated LMP2A in an adhe-
sion-dependent manner in intact cells (Scholle et al.,
1999). However, fibronectin stimulation did not lead to
any further increase in phosphate incorporation by Csk
in vitro. Interestingly, Csk activity is thought to be regu-
lated primarily by changes in its intracellular localization,
depending on interactions with cytoskeletal and trans-
port proteins, relying on its SH2 and SH3 domains (Clou-
tier et al., 1995; Ford et al., 1994; Howell and Cooper,
1994; Superti-Furga et al., 1993)
Overexpression of LMP2A in 293 cells led to the in-
duction of tyrosine phosphorylation of several cellular
proteins with molecular weights between 70 and 80 kDa.
The LMP2A deletion mutants that were phosphorylation
defective in vitro and in vivo, D21–85 and D80–112, and
the individual ITAM mutants did not induce phosphory-
lation of these cellular proteins, whereas mutation of
Y112 alone had no effect. Therefore, the ability to induce
tyrosine phosphorylation of these cellular proteins
seems to depend on the presence of an intact ITAM
motif. It is interesting to note that LMP2A expression in B
cells leads to increased constitutive phosphorylation of
the 70-kDa protein kinase Syk whose expression is re-
stricted to cells of the hematopoietic lineage (Miller et al.,
1995). A homolog of Syk in epithelial cells has not been
described; however, the molecular weights of two of the
proteins whose phosphorylation is induced by LMP2A in
epithelial cells is similar.
The function of ITAM motifs in epithelial cells is not
well understood. The a6b4 integrin is one of few epithe-
lial cell molecules that contain an ITAM motif and an
assembly of hemidesmosomes depends on the a6b4
ITAM. While the mechanism is not understood, it has
been hypothesized that the ITAM motif in this case may
primarily be involved in direct assembly of structural
protein–protein complexes rather than signaling func-
tions (Mainiero et al., 1995).
This study reveals important differences in the regu-
lation of LMP2A phosphorylation in epithelial cells com-
pared to B cells. Y112 is essential for LMP2A phosphor-
ylation in B cells both in vivo and in vitro using B cellextracts, while a Y112F point mutant is phosphorylated in
epithelial cells in vivo. In addition, mutation of the ITAM
motif reduces but does not eliminate phosphorylation of
LMP2A in epithelial cells in vivo. LMP2A is constitutively
phosphorylated in B cells but its phosphorylation is reg-
ulated by the extracellular matrix in epithelial cells. This
is only apparent in vivo but not in vitro, suggesting that
specific regulatory factors are required in intact cells.
These differences provide further evidence that different
kinases mediate LMP2A phosphorylation in epithelial
cells. Continued studies are likely to identify signaling
pathways critical to epithelial cell behavior that are af-
fected by LMP2A.
MATERIALS AND METHODS
Cell lines and expression constructs
Human 293 embryonic kidney cells were routinely
maintained in Dulbecco’s modified Eagle medium
(DMEM-H) supplemented with 10% fetal bovine serum
and antibiotics. pLMP2AHA, as well as the LMP2A
deletion mutants pLMP2AD21–36, pLMP2AD21–64,
pLMP2AD21–85, and pLMP2AD80–112, have been de-
scribed previously (Fruehling et al., 1996). In addition to
the deletion, LMP2AD80–112 contains a tyrosine to phe-
nylalanine substitution at position 74. Point-mutant ex-
pression constructs have been described previously
(Fruehling and Longnecker, 1997). Tyrosines are substi-
tuted with phenylalanines. All cDNAs are tagged with a
hemagglutinin epitope (HA) at the carboxyl-terminus to
facilitate detection of the proteins. Transient transfec-
tions into 293 cells were performed using the calcium
phosphate transfection method according to standard
procedures.
Immunoblot analysis
Whole-cell extracts were prepared by lysis of tran-
siently transfected cells 48 h posttransfection in NP-40
lysis buffer [150 mM NaCl, 20 mM Tris (pH 7.5), 2 mM
EDTA, 1% (v/v) Nonidet-P40, 10 mg/ml aprotinin, 2 mM
PMSF, 1mM sodium orthovanadate]. Lysates were incu-
bated on ice for 15 min and clarified by centrifugation in
a microcentrifuge at 13,000 rpm for 30 min at 4°C. Equal
amounts of protein were separated by SDS–PAGE and
transferred to Immobilon P membranes (Millipore). Im-
munoblotting was performed according to standard pro-
cedures. Phosphotyrosine-containing proteins were de-
tected with the 4G10 monoclonal antibody (Upstate Bio-
technology Inc.). LMP2A was detected with a polyclonal
anti-HA antibody (Santa Cruz).
Immunofluorescence analysis
Transiently transfected 293 cells were seeded onto
tissue culture slides and allowed to attach for 4 h. Cells
were fixed for 5 min in 1:1 methanol:acetone at 220°C
214 SCHOLLE, LONGNECKER, AND RAAB-TRAUBand nonspecific binding was blocked with 20% normal
goat serum for 20 min. Primary antibodies were diluted in
PBS and applied for 45 min. Secondary anti-mouse an-
tibodies conjugated to FITC or anti-rabbit antibodies con-
jugated to Texas Red were diluted in 20% normal goat
serum and applied for 30 min. Slides were mounted after
extensive washing in PBS using anti-fade mounting me-
dium (Vectashield). Tyrosine-phosphorylated proteins
were detected with the PY20 antiphosphotyrosine anti-
body (Santa Cruz) at 1:100 dilution and LMP2A was
detected with a polyclonal HA antibody at 1:50 dilution
(Santa Cruz).
Immunoprecipitations and immune complex kinase
assays
After preclearing with 20 ml protein-G coupled to
Sepharose, LMP2A and mutants were immunoprecipi-
tated from 500 mg of total protein, diluted to 500 ml in
lysis buffer overnight at 4°C with an anti-HA monoclonal
antibody conjugated to Sepharose beads (BABCO). Im-
munoprecipitates were washed three times in NP-40
lysis buffer and twice in kinase buffer (20 mM HEPES, 5
mM MnCl2). Kinase reactions were initiated by addition
of 25 ml kinase buffer containing 10 mCi g[32P]ATP for 15
min at room temperature. Reactions were stopped by
addition of ice-cold lysis buffer, washed three times, and
the products separated by SDS–PAGE after addition of
25 ml SDS sample buffer and visualized by autoradiog-
raphy.
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